ATORVASTATIN 10mg. IP + ASPIRIN 75mg. IP

A combination drug of blood-thinning and cholesterol-lowering agents is primarily taken to prevent heart attack and stroke. Reduces levels of total cholesterol, low-density lipoprotein (LDL)-cholesterol, triglyceride, and very low-density lipoprotein (VLDL)-cholesterol and increases high-density lipoprotein (HDL)-cholesterol. (H S Malhotra, 2001) Prevents cardiovascular events in patients with cardiac risk and treats abnormal cholesterol levels in the body. (Nikunj Satani, 2021) Reduces the occurrence of complications and hospitalization time and increases the survival rate of acute ischemic stroke patients. (Wanhui Li, 2020) Displays a better effective rate in treating acute ischemic stroke than aspirin alone. (Wanhui Li, 2020) Shows a beneficial role in cerebral circulation and cerebral parenchyma during ischemic stroke and reperfusion and protects the nerves of patients with acute ischemic stroke. (Wanhui Li, 2020) A potential drug that reduces the formation of cholesterol and inhibits the formation of blood clots. Improves inflammatory responses and accelerates platelet function, vascular endothelial cell function, and blood coagulation system after coronary artery bypass grafting. (Kazuo Nakamura, 2006)